SeaStar Medical Holding Corp (ICU) has a current Price-to-Book (P/B) ratio of 0.78. Compared to its 3-year average P/B ratio of -0.54, the current P/B ratio is approximately -245.75% higher. Relative to its 5-year average P/B ratio of -6.18, the current P/B ratio is about -112.65% higher. SeaStar Medical Holding Corp (ICU) has a Forward Free Cash Flow (FCF) yield of approximately -149.70%. Compared to its 3-year average FCF yield of -98.04%, the current FCF yield is approximately 52.70% lower. Relative to its 5-year average FCF yield of -88.71%, the current FCF yield is about 68.75% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for ICU competitors is 2.85, providing a benchmark for relative valuation. SeaStar Medical Holding Corp Corp (ICU.O) exhibits a P/S ratio of 6.57, which is 130.41% above the industry average. Given its robust revenue growth of 169.12%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of ICU increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of ICU in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is ICU currently overvalued or undervalued?

What is SeaStar Medical Holding Corp (ICU) fair value?

ICU's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of SeaStar Medical Holding Corp (ICU) is between 2.65 to 5.25 according to relative valuation method.

How does ICU's valuation metrics compare to the industry average?

The average P/S ratio for ICU's competitors is 2.85, providing a benchmark for relative valuation. SeaStar Medical Holding Corp Corp (ICU) exhibits a P/S ratio of 6.57, which is 130.41% above the industry average. Given its robust revenue growth of 169.12%, this premium appears sustainable.

What is the current P/B ratio for SeaStar Medical Holding Corp (ICU) as of Mar 03 2026?

As of Mar 03 2026, SeaStar Medical Holding Corp (ICU) has a P/B ratio of 0.78. This indicates that the market values ICU at 0.78 times its book value.

What is the current FCF Yield for SeaStar Medical Holding Corp (ICU) as of Mar 03 2026?

As of Mar 03 2026, SeaStar Medical Holding Corp (ICU) has a FCF Yield of -149.70%. This means that for every dollar of SeaStar Medical Holding Corp's market capitalization, the company generates -149.70 cents in free cash flow.

What is the current Forward P/E ratio for SeaStar Medical Holding Corp (ICU) as of Mar 03 2026?

As of Mar 03 2026, SeaStar Medical Holding Corp (ICU) has a Forward P/E ratio of -0.60. This means the market is willing to pay $-0.60 for every dollar of SeaStar Medical Holding Corp's expected earnings over the next 12 months.

What is the current Forward P/S ratio for SeaStar Medical Holding Corp (ICU) as of Mar 03 2026?

As of Mar 03 2026, SeaStar Medical Holding Corp (ICU) has a Forward P/S ratio of 6.57. This means the market is valuing ICU at $6.57 for every dollar of expected revenue over the next 12 months.

ICU Valuation